Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sensitive and Specific Global Cell Surface N-Glycoproteomics Shows Profound Differences Between Glycosylation Sites and Subcellular Components. | Anal Chem | 2023 | 37956981 | PubTator, text mining | PubMed |
| A Recalcitrant Case of Senear-Usher Syndrome Treated With Rituximab. | Cureus | 2023 | 37954755 | PubTator, text mining | PubMed |
| Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms. | J Exp Clin Cancer Res | 2023 | 37951921 | PubTator, text mining | PubMed |
| Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation. | BMC Immunol | 2023 | 37940861 | PubTator, text mining | PubMed |
| Automated exploitation of deep learning for cancer patient stratification across multiple types. | Bioinformatics | 2023 | 37934154 | PubTator, text mining | PubMed |
| New Organotin (IV) Compounds Derived from Dehydroacetic Acid and Thiosemicarbazides: Synthesis, Rational Design, Cytotoxic Evaluation, and Molecular Docking Simulation. | Bioinorg Chem Appl | 2023 | 37920233 | PubTator, text mining | PubMed |
| Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. | Cancer Res Commun | 2023 | 37910143 | PubTator, text mining | PubMed |
| Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms. | Cells | 2023 | 37887317 | PubTator, text mining | PubMed |
| Involvement of palms and soles in patients with autoimmune bullous diseases: a comparative analysis of a diagnostically relevant localization. | Front Immunol | 2023 | 37885886 | PubTator, text mining | PubMed |
| Retrospective analysis of autoimmune bullous diseases in Middle Franconia. | Front Immunol | 2023 | 37881435 | PubTator, text mining | PubMed |
| Selective targeting of parallel G-quadruplex structure using L-RNA aptamer. | Nucleic Acids Res | 2023 | 37870474 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature. | Sci Rep | 2023 | 37845218 | PubTator, text mining | PubMed |
| Pemphigus Vegetans of Hallopeau: A Case Report. | Acta Dermatovenerol Croat | 2023 | 37843091 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck Cancer. | Cancers (Basel) | 2023 | 37835579 | PubTator, text mining | PubMed |
| B Cell Tolerance and Targeted Therapies in SLE. | J Clin Med | 2023 | 37834911 | PubTator, text mining | PubMed |
| Pemphigus vulgaris mimicking Steven-Johnson syndrome/toxic epidermal necrolysis: report of an unusual case. | Dermatol Reports | 2023 | 37822989 | PubTator, text mining | PubMed |
| Genetic diagnosis of a rare COL7A1 variant causing dystrophic epidermolysis bullosa pruriginosa through whole‑exome sequencing. | Exp Ther Med | 2023 | 37822584 | PubTator, text mining | PubMed |
| Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters. | J Clin Invest | 2023 | 37815865 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023. | Hum Vaccin Immunother | 2023 | 37814513 | PubTator, text mining | PubMed |
| Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA. | Nucleic Acids Res | 2023 | 37811881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=12